This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Dysmenorrhea Treatment Market

Market research report analyzing sales of dysmenorrhea treatment market, demand of dysmenorrhea treatment, and trend analysis of dysmenorrhea treatment market till 2032

Dysmenorrhea Treatment Market By Product Type, End-User & Region - Forecast 2022 – 2032

Dysmenorrhea Treatment Market Snapshot (2022-2032)

[298 Pages Report] The global dysmenorrhea treatment market is expected to be valued at US$ 5937.8 Million in 2022, and is projected to reach US$ 13179.8 Million by 2032. A CAGR worth 8.3% is expected for the market during the 2022-2032 forecast period.

Dysmenorrhea is a clinical term for menstrual cramps in which a woman experiences severe pain or cramps in her abdominal area that may spread to her lower legs and back. Most women begin suffering dysmenorrhea throughout adolescence, generally after four to five years of first menstrual cycle.

Prostaglandins are substances that are produced in the uterine lining during menstruation. These prostaglandins generate uterine muscular spasms, which cause discomfort and reduce blood supply and oxygen to the uterus. Menstrual problems can be caused by a wide range of underlying conditions.

Lifestyle modifications, changes in the environment, and food preferences all have a significant influence on human bodies, which has raised the occurrence of dysmenorrhea amongst women. The increased frequency of dysmenorrhea has led to increased health consciousness among women to treat the illness, which is projected to drive market growth.

The increased consumer awareness of dysmenorrhea therapy, as well as the low cost of over-the-counter medications, are two important factors driving growth in the dysmenorrhea treatment market. The increased usage of drugs to relieve pain during menstruation, in turn, drives the growth of the worldwide dysmenorrhea treatment market.

Additionally, throughout the forecast period, the increase in technological improvement in the healthcare industry is likely to fuel the growth of the dysmenorrhea treatment market. However, long-term treatment side effects and issues, the high morbidity of menstrual cramps leading to inadequate treatments, and traditional family values are expected to stymie the growth of the dysmenorrhea treatment industry.

Report Attribute

Details

Expected Market Value (2022)

US$ 5937.8 Million

Projected Forecast Value (2032)

US$ 13179.8 Million

Anticipated Growth Rate (2022-2032)

8.3%

Customize this Report

Let us know your requirement to get
100% FREE customization

What Are The Major Factors Boosting The Dysmenorrhea Treatment Market?

The growing healthcare spending, which aids in the improvement of infrastructure, is a crucial element driving the development rate of the dysmenorrhea treatment market. Furthermore, numerous government organizations intend to improve healthcare infrastructure by boosting financing, which would have an impact on market dynamics.

People's changing lifestyles are expected to have an impact on market dynamics throughout the projected period of 2022-2032. Changing lifestyles, along with bad eating habits, have a significant influence on the human body. As a result, the prevalence of dysmenorrhea/menstrual cramps among women has increased. Climate factors are also thought to increase the likelihood of menstruation cramps.

Furthermore, a growing number of government measures to raise awareness and increase the aging population would result in the dysmenorrhea treatment market. Along with this, increased disposable income and urbanization will boost the market's growth rate.

What Are The Factors Hindering The Dysmenorrhea Treatment market?

The high cost of care, on the other hand, will impede the growth rate of the dysmenorrhea treatment market during the forecast period of 2022-2032. The dysmenorrhea treatment market will face challenges due to a lack of healthcare infrastructure in emerging nations and a stringent regulatory environment. Furthermore, a lack of public awareness and inadequate reimbursement policies may hinder and impede market expansion during the projection period of 2022-2032.

Additionally, challenges related with long-term care and other side effects and issues, the high morbidity of menstrual cramps due to insufficient treatments, and traditional family values are expected to stymie the growth of the dysmenorrhea treatment market.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Is The Outlook Of The Disease Segment Of The Dysmenorrhea Treatment Market?

During the projected period of 2022-2032, the endometriosis segment is expected to gain a global market share of 35% during the forecast period. The rising prevalence of endometriosis is projected to drive the dysmenorrhea treatment market forward.

The global prevalence of disorders such as endometriosis, the primary cause of secondary dysmenorrhea, is also increasing. Endometriosis affects an estimated 1 in 10 women throughout their reproductive years, or around 176 million people globally, according to an article titled "Understanding Endometriosis - the Basics" published in July 2021. This element is predicted to have a substantial influence on market growth. As a result of the aforementioned causes, the nonsteroidal anti-inflammatory medicines category is predicted to considerably contribute to market growth.

What Is The Outlook Of The North American Dysmenorrhea Treatment Market?

In terms of market share and revenue, the North American market is expected to be the dominant market for dysmenorrhea treatments during the projection period of 2022-2032. The analysts at Future Market Insights predict that by 2022, the market of dysmenorrhea treatments in North America is expected to acquire a global market size of 29%.

This will maintain its supremacy throughout the projected period. This is because technological innovation and increased healthcare spending will drive the market's growth rate in this area even faster. Furthermore, the presence of significant key competitors and rising pharmaceutical consumption will drive the market's development rate in this area even faster.

Furthermore, a growth in R&D procedures for generating new pharmaceuticals and assessing the potential of existing therapies may improve the market under consideration. For example, a January 2019 research titled "Continuous vs. cyclic combined hormonal contraceptives for the treatment of dysmenorrhea: a comprehensive review" found that flexible/extended combined hormonal contraceptives (CHC) culminated in four fewer days of dysmenorrhea than the cyclic regimen. Such research projects are likely to considerably contribute to the market's growth.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

How Is The European Market Driving Demand For Dysmenorrhea Treatments?

By 2022, Europe will hold approximately 24% of the global market share. This region is expected to be one of the fastest growing markets for the dysmenorrhea treatment during the forecast period, 2022-2032.

The increasing number of R&D activities is driving the market's expansion. This would give advantageous chances for the expansion of the dysmenorrhea treatments market. Leading corporations are investing in research and development. This brings up a lot of market opportunities.

What Can Be Expected From The APAC Region During The Forecast Period?

The Asia Pacific region is expected to develop at the fastest CAGR during the forecast period.

This is owing to a rise in the prevalence of Dysmenorrhea and menstrual health issues in this region for treatment. Furthermore, the expansion of healthcare infrastructure and growing government efforts would accelerate the market's growth rate in this area.

Market Competition

The key players of this market include Novartis Pharmaceuticals Corporation, Merck, Inc., Bayer Schering Pharma AG, Vanita Therapeutics, Nua, Cora, Alvogen, Pfizer, Inc., Roche Laboratories, Taj Pharmaceuticals, Ltd., Sanofi, Terramedic, Inc.

  • Nua announced the release of Cramp Comfort, a first-of-its-kind period pain relief solution, in December 2020. Nua, a women's health startup, has released a revolutionary self-heating patch that can deliver up to 8 hours of heat to alleviate period discomfort. Cramp Comfort is made completely of natural ingredients and was created after considerable research and a full grasp of client expectations. The price of a pack of three heat patches is INR 299.
  • Cora® debuted their fresh comfort-focused brand image, feel, and identity in 2022. Moreover, to rebrand, the company has expanded its product line with new wellness products to meet the needs of a wide range of consumers. The Comfort Fit TamponTM, The Got-You-Covered LinerTM, The Peace-of-Mind PadTM, and The Perfect Fit DiscTM are among the new product names.

Start-up scenario

  • Ovira, an Australian start-up, has released its flagship product. It is a TENS (Transcutaneous Electrical Nerve Stimulation) device, which operates by sending a mild electrical current via two compression pads positioned over the love handles, which contain the nerve roots that provide the sensory fibres to the uterus. Once implanted, the stimulation inhibits pain signals from reaching the brain, allowing uterine muscle relaxation and providing pain relief.
  • Gynica is a FemTech startup based in Israel. It is responsible for the creation of cannabis-based treatments for women's reproductive health. Gynica is a medical firm that is studying and developing marijuana treatments for gynecological disorders and symptoms. They are members of Station F's FemTech Cohort.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 8.3% from 2022 to 2032

Market value in 2022

US$ 5937.8 Million

Market value in 2032

US$ 13179.8 Million

Base Year for Estimation

2021

Historical Data

2017-2021

Forecast Period

2022-2032

Quantitative Units

USD Million for Value

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Diseases
  • Therapeutic Class
  • Region

Regions Covered

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • APAC
  • Japan
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Mexico
  • Brazil
  • Germany
  • Italy
  • France
  • U.K
  • Spain
  • Poland
  • Russia
  • China
  • India
  • ASEAN
  • Australia
  • New Zealand
  • Japan
  • GCC Countries
  • S. Africa
  • Northern Africa

Key Companies Profiled

  • Novartis Pharmaceuticals Corporation,
  • Merck, Inc.,
  • Bayer Schering Pharma AG,
  • Vanita Therapeutics,
  • Alvogen,
  • Pfizer, Inc.,
  • Nua
  • Cora
  • Roche Laboratories,
  • Taj Pharmaceuticals, Ltd.,
  • Sanofi,
  • Terramedic, Inc.

Customisation Scope

Available on Request

Key Segments Profiled In The Global Dysmenorrhea Treatment Market

Dysmenorrhea Treatment Market By Diseases:

  • Primary Dysmenorrhea
  • Secondary Dysmenorrhea
  • Endometriosis
  • Adenomyosis
  • Uterine Myomas
  • Endometrial Polyps
  • Cervical Stenosis
  • Obstructive Malformations Of Genital Tract

Dysmenorrhea Treatment Market By Therapeutic Class:

  • Non-Hormonal Medical Treatment
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
  • Non-Selective Nsaids
  • Cox-2 Inhibitors
  • Transdermal Glyceryl Trinitrate
  • Over-The-Counter (Otc) Medications
  • Hormonal Medicine Treatment
  • Combined Oral Contraceptive
  • Progestin Regimens
  • Levonorgestrel Intrauterine System (LN-IUS)
  • Surgical Options
  • Laparoscopy
  • Hysterectomy
  • Presacral Neurectomy
  • Laparoscopic Uterosacral Nerve Ablation (LUNA)
  • Intrauterine Device (IUD)

Dysmenorrhea Treatment Market By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • APAC
  • Japan
  • MEA

Frequently Asked Questions

The global dysmenorrhea treatment market is expected to grow at a 8.3% CAGR and secure US$ 13179.8 Million by 2032.

North America is expected to be the fastest growing market for dysmenorrhea treatments during the forecast period and is expected to acquire a market share of 29% in 2022.

Novartis Pharmaceuticals Corporation, Merck, Inc., Bayer Schering Pharma AG, Vanita Therapeutics, Alvogen, Pfizer, Inc., Nua, Cora, Roche Laboratories, Taj Pharmaceuticals, Ltd., Sanofi, Terramedic, Inc. are some of the known players in the dysmenorrhea treatment market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions/Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Disease Type modifications /Innovation

4. Key Success Factors

    4.1. Strategic Developments

    4.2. Key regulations

    4.3. Disease Type USPs /Technology

    4.4. List of Manufacturers and Providers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP outlook

        5.1.2. Increasing R&D Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. New Disease Type launches

        5.2.2. Cost of Disease Types

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Dysmenorrhea Treatment Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Disease Type

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Dysmenorrhea Treatment Market Value Analysis 2016–2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2016–2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032, by Disease Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Disease Types & Services, 2016–2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2022-2032

        8.3.1. Primary Dysmenorrhea

        8.3.2. Secondary Dysmenorrhea

        8.3.3. Endometriosis

        8.3.4. Adenomyosis

        8.3.5. Uterine Myomas

        8.3.6. Endometrial Polyps

        8.3.7. Cervical Stenosis

        8.3.8. Obstructive Malformations of Genital Tract

    8.4. Market Attractiveness Analysis By Disease Type

9. Global Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032, by Therapeutic Class

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Class , 2016–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Class , 2022-2032

        9.3.1. Non-Hormonal Medical Treatment

            9.3.1.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

                9.3.1.1.1. Non-Selective NSAIDs

                9.3.1.1.2. Cox-2 Inhibitors

                9.3.1.1.3. Transdermal Glyceryl Trinitrate

                9.3.1.1.4. Over-the-Counter (OTC) Medications

        9.3.2. Hormonal Medicine Treatment

            9.3.2.1. Combined Oral Contraceptive

            9.3.2.2. Progestin Regimens

            9.3.2.3. Levonorgestrel Intrauterine System (LN-IUS)

        9.3.3. Surgical Options

            9.3.3.1. Laparoscopy

            9.3.3.2. Hysterectomy

            9.3.3.3. Presacral Neurectomy

            9.3.3.4. Laparoscopic Uterosacral Nerve Ablation (NUSA)

            9.3.3.5. Intrauterine Device (IUD)

    9.4. Market Attractiveness Analysis By Therapeutic Class

10. Global Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2021

    10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Disease Type

        11.3.3. By Therapeutic Class

    11.4. Market Attractiveness Analysis

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. Latin America Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Disease Type

        12.3.3. By Therapeutic Class

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Europe Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. Russia

            13.3.1.7. Rest of Europe

        13.3.2. By Disease Type

        13.3.3. By Therapeutic Class

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. South Asia Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Disease Type

        14.3.3. By Therapeutic Class

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. East Asia Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

            15.3.1.4. Rest of East Asia

        15.3.2. By Disease Type

        15.3.3. By Therapeutic Class

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Oceania Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Disease Type

        16.3.3. By Therapeutic Class

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. South Africa

            17.3.1.3. Rest of Middle East and Africa

        17.3.2. By Disease Type

        17.3.3. By Therapeutic Class

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. Key and Emerging Countries Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. U.S. Dysmenorrhea Treatment Market Analysis

        18.2.1. By Disease Type

        18.2.2. By Therapeutic Class

    18.3. Canada Dysmenorrhea Treatment Market Analysis

        18.3.1. By Disease Type

        18.3.2. By Therapeutic Class

    18.4. Mexico Dysmenorrhea Treatment Market Analysis

        18.4.1. By Disease Type

        18.4.2. By Therapeutic Class

    18.5. Brazil Dysmenorrhea Treatment Market Analysis

        18.5.1. By Disease Type

        18.5.2. By Therapeutic Class

    18.6. U.K. Dysmenorrhea Treatment Market Analysis

        18.6.1. By Disease Type

        18.6.2. By Therapeutic Class

    18.7. Germany Dysmenorrhea Treatment Market Analysis

        18.7.1. By Disease Type

        18.7.2. By Therapeutic Class

    18.8. France Dysmenorrhea Treatment Market Analysis

        18.8.1. By Disease Type

        18.8.2. By Therapeutic Class

    18.9. Italy Dysmenorrhea Treatment Market Analysis

        18.9.1. By Disease Type

        18.9.2. By Therapeutic Class

    18.10. Spain Dysmenorrhea Treatment Market Analysis

        18.10.1. By Disease Type

        18.10.2. By Therapeutic Class

    18.11. BENELUX Dysmenorrhea Treatment Market Analysis

        18.11.1. By Disease Type

        18.11.2. By Therapeutic Class

    18.12. Russia Dysmenorrhea Treatment Market Analysis

        18.12.1. By Disease Type

        18.12.2. By Therapeutic Class

    18.13. China Dysmenorrhea Treatment Market Analysis

        18.13.1. By Disease Type

        18.13.2. By Therapeutic Class

    18.14. Japan Dysmenorrhea Treatment Market Analysis

        18.14.1. By Disease Type

        18.14.2. By Therapeutic Class

    18.15. South Korea Dysmenorrhea Treatment Market Analysis

        18.15.1. By Disease Type

        18.15.2. By Therapeutic Class

    18.16. India Dysmenorrhea Treatment Market Analysis

        18.16.1. By Disease Type

        18.16.2. By Therapeutic Class

    18.17. ASEAN Dysmenorrhea Treatment Market Analysis

        18.17.1. By Disease Type

        18.17.2. By Therapeutic Class

    18.18. Australia Dysmenorrhea Treatment Market Analysis

        18.18.1. By Disease Type

        18.18.2. By Therapeutic Class

    18.19. New Zealand Dysmenorrhea Treatment Market Analysis

        18.19.1. By Disease Type

        18.19.2. By Therapeutic Class

    18.20. GCC Countries Dysmenorrhea Treatment Market Analysis

        18.20.1. By Disease Type

        18.20.2. By Therapeutic Class

    18.21. Turkey Dysmenorrhea Treatment Market Analysis

        18.21.1. By Disease Type

        18.21.2. By Therapeutic Class

    18.22. South Africa Dysmenorrhea Treatment Market Analysis

        18.22.1. By Disease Type

        18.22.2. By Therapeutic Class

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Disease Type foot print by Players

        19.4.3. Channel Foot Print by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep dive

        20.3.1. Novartis Pharmaceutical Corporation

            20.3.1.1. Overview

            20.3.1.2. Disease Type Portfolio

            20.3.1.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.1.4. Sales Footprint

            20.3.1.5. Strategy Overview

        20.3.2. Merck Inc.

            20.3.2.1. Overview

            20.3.2.2. Disease Type Portfolio

            20.3.2.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.2.4. Sales Footprint

            20.3.2.5. Strategy Overview

        20.3.3. Bayer AG

            20.3.3.1. Overview

            20.3.3.2. Disease Type Portfolio

            20.3.3.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.3.4. Sales Footprint

            20.3.3.5. Strategy Overview

        20.3.4. Vanita Therapeutics

            20.3.4.1. Overview

            20.3.4.2. Disease Type Portfolio

            20.3.4.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.4.4. Sales Footprint

            20.3.4.5. Strategy Overview

        20.3.5. Alvogen

            20.3.5.1. Overview

            20.3.5.2. Disease Type Portfolio

            20.3.5.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.5.4. Sales Footprint

            20.3.5.5. Strategy Overview

        20.3.6. Pfizer Inc.

            20.3.6.1. Overview

            20.3.6.2. Disease Type Portfolio

            20.3.6.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.6.4. Sales Footprint

            20.3.6.5. Strategy Overview

        20.3.7. Roche Laboratories

            20.3.7.1. Overview

            20.3.7.2. Disease Type Portfolio

            20.3.7.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.7.4. Sales Footprint

            20.3.7.5. Strategy Overview

        20.3.8. Taj Pharmaceuticals Ltd.

            20.3.8.1. Overview

            20.3.8.2. Disease Type Portfolio

            20.3.8.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.8.4. Sales Footprint

            20.3.8.5. Strategy Overview

        20.3.9. Sanofi

            20.3.9.1. Overview

            20.3.9.2. Disease Type Portfolio

            20.3.9.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.9.4. Sales Footprint

            20.3.9.5. Strategy Overview

        20.3.10. Terramedic Inc.

            20.3.10.1. Overview

            20.3.10.2. Disease Type Portfolio

            20.3.10.3. Profitability by Market Segments (Disease Type/Channel/Region)

            20.3.10.4. Sales Footprint

            20.3.10.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology
Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Dysmenorrhea Treatment Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 02: Global Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 03: Global Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 04: Global Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Region

Table 05: North America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 06: North America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 07: North America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 08: Latin America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 09: Latin America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 10: Latin America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 11: Europe Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 12: Europe Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 13: Europe Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 14: South Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 15: South Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 16: South Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 17: East Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 18: East Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 19: East Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 20: Oceania Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 21: Oceania Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 22: Oceania Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class

Table 23: Middle East and Africa Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country

Table 24: Middle East and Africa Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type

Table 25: Middle East and Africa Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Dysmenorrhea Treatment Market Volume (in 000' Units) Analysis, 2016-2021

Figure 02: Global Dysmenorrhea Treatment Market Volume Forecast (in 000' Units), 2022-2032

Figure 03: Dysmenorrhea Treatment Pricing Analysis (US$) Per Disease Type, By Region, 2021

Figure 04: Dysmenorrhea Treatment Pricing Analysis (US$) Per Disease Type, By Region, 2021

Figure 05: Global Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 06: Global Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 07: Global Dysmenorrhea Treatment Market Absolute $ Opportunity, 2022-2032

Figure 08: Global Dysmenorrhea Treatment Market Share Analysis (%), By Disease Type, 2022-2032

Figure 09: Global Dysmenorrhea Treatment Market Y-o-Y Analysis (%), By Disease Type, 2022-2032

Figure 10: Global Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 11: Global Dysmenorrhea Treatment Market Share Analysis (%), By Therapeutic Class, 2022-2032

Figure 12: Global Dysmenorrhea Treatment Market Y-o-Y Analysis (%), By Therapeutic Class, 2022-2032

Figure 13: Global Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 14: Global Dysmenorrhea Treatment Market Share Analysis (%), By Region, 2022-2032

Figure 15: Global Dysmenorrhea Treatment Market Y-o-Y Analysis (%), By Region, 2022-2032

Figure 16: Global Dysmenorrhea Treatment Market Attractiveness Analysis by Region, 2022-2032

Figure 17: North America Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 18: North America Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 19: North America Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 20: North America Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 21: North America Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 22: North America Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 23: North America Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 24: North America Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 25: Latin America Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 26: Latin America Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 27: Latin America Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 28: Latin America Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 29: Latin America Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 30: Latin America Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 31: Latin America Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 32: Latin America Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 33: Europe Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 34: Europe Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 35: Europe Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 36: Europe Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 37: Europe Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 38: Europe Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 39: Europe Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 40: Europe Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 41: South Asia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 42: South Asia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 43: South Asia Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 44: South Asia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 45: South Asia Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 46: South Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 47: South Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 48: South Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 49: East Asia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 50: East Asia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 51: East Asia Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 52: East Asia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 53: East Asia Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 54: East Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 55: East Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 56: East Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 57: Oceania Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 58: Oceania Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 59: Oceania Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 60: Oceania Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 61: Oceania Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 62: Oceania Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 63: Oceania Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 64: Oceania Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 65: Middle East and Africa Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 66: Middle East and Africa Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 67: Middle East and Africa Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E)

Figure 68: Middle East and Africa Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021

Figure 69: Middle East and Africa Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032

Figure 70: Middle East and Africa Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032

Figure 71: Middle East and Africa Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032

Figure 72: Middle East and Africa Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032

Figure 73: U. S. Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 74: U. S. Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 75: U. S. Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 76: Canada Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 77: Canada Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 78: Canada Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 79: Mexico Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 80: Mexico Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 81: Mexico Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 82: Brazil Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 83: Brazil Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 84: Brazil Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 85: U. K. Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 86: U. K. Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 87: U. K. Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 88: Germany Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 89: Germany Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 90: Germany Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 91: France Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 92: France Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 93: France Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 94: Italy Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 95: Italy Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 96: Italy Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 97: Spain Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 98: Spain Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 99: Spain Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 100: Russia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 101: Russia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 102: Russia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 103: China Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 104: China Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 105: China Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 106: Japan Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 107: Japan Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 108: Japan Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 109: South Korea Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 110: South Korea Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 111: South Korea Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 112: India Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 113: India Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 114: India Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 115: ASEAN Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 116: ASEAN Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 117: ASEAN Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 118: Australia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 119: Australia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 120: Australia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 121: New Zealand Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 122: New Zealand Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 123: New Zealand Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 124: GCC Countries Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 125: GCC Countries Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 126: GCC Countries Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 127: Turkey Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 128: Turkey Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 129: Turkey Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Figure 130: South Africa Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032

Figure 131: South Africa Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E)

Figure 132: South Africa Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Aflatoxicosis Treatment Market

Published : July 2017

Healthcare

Scabies Treatment Market

Published : April 2016

Healthcare

Allergy Treatment Market

Published : April 2016

Healthcare

Bronchitis Treatment Market

Published : March 2016

Google translate

Dysmenorrhea Treatment Market